|
|
Ventiv Health Inc. (VTIV) |
|
CEOCFO
Interview Index |
This is a printer friendly page! Ventiv Health, market leader in sales,
marketing and clinical outsourced solutions, continues to see strong demand for their
service from enabling small- and medium-sized pharmaceutical companies, as well as growing
demand from larger pharmaceutical companies
|
Weve had a very busy year over 2004. Its been an incredibly strong year, particularly in terms of winning new business. We have won new business worth roughly $160 to $170 million on an annualized basis. We have added 1,600 representatives to our sales and marketing business; indeed a very large amount of new business on top of our base business. This has allowed us to continue to grow strongly in our sales and marketing business. In tandem with that we have also substantially broadened the footprint of the organization in two ways. Organically weve added and introduced a number of new offerings to our clients, leveraging existing capabilities of the organization, such as introducing The Therapeutic Institute, Professional Development services, Recruiting services and our Total Data Solutions services, among others. Secondly, weve also made two acquisitions that have further broadened the footprint of the organization. In June of this year (2004) we acquired the Franklin Group, a leading player in the compliance arena as well as in patient assistance. Most recently in September (2004) we announced the acquisition of Smith Hanley Corporation, a leading player in the outsourced clinical staffing business and recruiting arena. This gives us a leadership position in that part of the market, late stage clinical, just before commercialization. So, weve grown very substantially both from an organic point of view and weve further strengthened the organization with a couple of key acquisitions, enabling us to further build out our market leadership position across multiple arenas. - Eran Broshy |
|
|
To view Releases highlight & left click on the company name!
|
|
ceocfointerviews.com does not purchase or
make
recommendation on stocks based on the interviews published.
.